Accolade Inc (ACCD)
7.21
-0.09
(-1.23%)
USD |
NASDAQ |
May 10, 16:00
7.21
0.00 (0.00%)
After-Hours: 18:14
Accolade SG&A Expense (Quarterly): 39.04M for Feb. 29, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 39.04M |
November 30, 2023 | 41.70M |
August 31, 2023 | 40.34M |
May 31, 2023 | 41.11M |
February 28, 2023 | 43.45M |
November 30, 2022 | 45.06M |
August 31, 2022 | 45.96M |
May 31, 2022 | 45.85M |
February 28, 2022 | 53.10M |
November 30, 2021 | 46.08M |
August 31, 2021 | 50.18M |
Date | Value |
---|---|
May 31, 2021 | 36.51M |
February 28, 2021 | 20.92M |
November 30, 2020 | 17.06M |
August 31, 2020 | 14.33M |
May 31, 2020 | 12.98M |
February 29, 2020 | 12.88M |
November 30, 2019 | 16.48M |
August 31, 2019 | 13.63M |
May 31, 2019 | 13.22M |
February 28, 2019 | 11.28M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
12.88M
Minimum
Feb 2020
53.10M
Maximum
Feb 2022
32.49M
Average
39.69M
Median
SG&A Expense (Quarterly) Benchmarks
HealthStream Inc | 20.08M |
HealthEquity Inc | 45.85M |
Trxade Health Inc | 3.578M |
Simulations Plus Inc | 7.467M |
Schrodinger Inc | 35.71M |